drugset / Trial / NCT01932502
Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy
Phase 4
Unknown
21 enrolled
St. Joseph's Hospital and Medical Center, Phoenix
H. Lundbeck A/S · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to examine the clinical safety, tolerability, and efficacy of clobazam (Onfi) when it replaces the pre-existing clonazepam therapy in patients with refractory epilepsy.
Timeline
- Start
- 2013-02
- Primary completion
- 2017-06
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clobazam | Small molecule | 40 mg | — |
| Subject | Clobazam | Small molecule | 60 mg | — |